Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

Testosterone replacement can help women with low libido and mood, but they need to have enough estrogen first to avoid side effects.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

Testosterone Replacement Therapy can improve sexual health in postmenopausal women with low sexual desire, but more research is needed on its long-term effects.

Hormone therapy improves mental well-being in transgender individuals but requires ongoing health monitoring.

Testosterone therapy increases bone density in older men with low testosterone levels.

Testosterone therapy improves physical function, strength, and body composition in older men with low testosterone levels.

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

Activating ER-β, not ER-α, improves skin cell growth and wound healing.

The document concludes that hair loss in women is complex, often linked to aging, health conditions, and nutritional deficiencies, and emotional impacts should not be underestimated.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

Testosterone replacement therapy helps manage deficiency and has various methods, but requires careful monitoring to avoid side effects.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Facial aging is caused by natural processes and external factors, and can be managed with preventative measures and a variety of treatments tailored to individual needs.

The document concludes that individualized treatment and lifestyle changes are important for managing menopause symptoms and health risks.

New treatments for skin and hair repair show promise, but further improvements are needed.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

Manage women's cholesterol with diet, exercise, and careful treatment choices, especially during pregnancy, PCOS, and menopause.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

Testosterone supplements can increase muscle mass and strength in older men with low levels, but long-term effects and risks need more research.

Taking oral testosterone with or without dutasteride increases testosterone levels and could be an effective treatment for low testosterone.

Hair loss in women can be slowed with treatment, but more research needed for better solutions.

Steroid hormones are crucial for body functions and have various medical uses, but their misuse can lead to dependence.

Skin changes can help diagnose and manage endocrine disorders like thyroid problems, diabetes, and adrenal gland conditions.

Testosterone therapy helps boys with hormone deficiencies develop normal male characteristics and grow properly.

More research is needed on the health effects of hormone therapy for transgender and nonbinary people.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.